Prevalence, Clinical Characteristics, and Risk Among Patients with Ischemic Heart Disease in the Young Jordanian Population

Figures & data

Table 1 Cut-off Values of Biochemical Factors

Biochemical Factor	Normal	High
Blood pressure	120/80 mm Hg	>130–85 mm Hg
LDL	<100 mg/dL	130 to 159 mg/dL
HDL	40 mg/dL or higher	-
Triglycerides	<150 mg/dL	>150 to 199 mg/dL
Total serum cholesterol	<200 mg/dL	>200 mg/dL
BMI	18.5–24.9	25–29.9
Random blood glucose	<200 mg/dL	>200 mg/dL
HbA1c	Below 6.0%	-

Table 2 Demographic Details

Variable		n (%)
Gender (n, %)	Female	31 (8.7%)
	Male	327 (91.3%)
Age (n, %)	24 years to 29 years	10 (2.8%)
	30 years to 35 years	52 (14.5%)
	36 years to 41 years	160 (44.7%)
	42 years to 49 years	136 (40%)
First diagnosis (n, %)	Acute mi	160 (44.7%)
	Stable angina pectoris	24 (6.7%)
	Unstable angina	174 (48.6%)
Smoking status (n, %)	Current smoker	282 (78.8%)
	Ex-smoker	26 (7.3%)
	Non-smoker	50 (14.0%)
Variable		Mean (±SD)
Height, cm		151.41 (±57.124)
Weight, Kg		77.49 (±32.292)
BMI, kg/m^2		25.43 (±10.743)
HbA1c		5.11 (±3.525)
Monocytes differential		7.75 (±2.431)

Table 3 Gender Effects on Biochemical Factors, Associated Risk Factors and Beta-Blocker Intake in Patients with IHD

Variables		Male, n (%)	Female, n (%)	P-value
WBC count	Low	0	2 (3.3%)	0.004
	Normal	223 (68.2%)	18 (60%)
	High	104 (31.8%)	11 (36.7%)
Platelets count	Low	11 (3.3%)	2 (3.3%)	0.630
	Normal	290 (88.7%)	25 (83.3%)
	High	26 (8.0%)	4 (13.3%)
Initial troponin	Low	0	0	0.199
	Normal	40 (12.2%)	7 (22.6%)
	High	107 (32.7%)	7 (22.6%)
	NA	180 (55%)	17 (54.8%)
CK-MB	Low	0	1 (3.2%)	0.014
	Normal	70 (21.4%)	7 (22.6%)
	High	123 (37.6%)	11 (35.5%)
	NA	134 (41%)	12 (38.7%)
Initial CK	Low	0	0	0.610
	Normal	90 (27.5%)	11 (35.5%)
	High	104 (31.8%)	8 (25.8%)
	NA	133 (40.7%)	12 (38.7%)
HDL level	Low	237 (72.5%)	22 (71.0%)	0.793
	Normal	72 (22.1%)	8 (25.8%)
	High	3 (0.9%)	0
	NA	15 (4.6%)	1 (3.2%)
LDL level	Low	1 (0.3%)	0	0.860
	Normal	252 (77.1%)	22 (71%)
	High	56 (17.1%)	7 (22.6%)
	NA	18 (5.5%)	2 (6.5%)
Triglyceride level	Low	2 (0.6%)	0	0.172
	Normal	123 (37.6%)	18 (58.1%)
	High	188 (57.5%)	13 (41.9%)
	NA	14 (4.3%)	0
Cholesterol level	Low	6 (1.8%)	2 (6.6%)	0.071
	Normal	230 (70.3%)	17 (56.8%)
	High	77 (23.6%)	11 (35.5%)
	NA	14 (4.3%)	1 (3.2%)
Glucose level	Low	3 (0.9%)	1 (3.2%)	0.555
	Normal	129 (39.4%)	10 (32.3%)
	High	168 (51.4%)	18 (58.1%)
	NA	27 (8.3%)	2 (6.5%)
Diabetes mellitus	Yes	88 (26.9%)	13 (41.9%)	0.078
	No	239 (73.1%)	18 (58.1%)
Hypertension	Yes	145 (44.3%)	17 (54.8%)	0.091
	No	182 (55.7%)	14 (45.2%)
Family history	Yes	87 (26.6%)	7 (22.6%)	0.634
	No	240 (73.4%)	24 (77.4%)
Obesity	Yes	160 (48.9%)	13 (41.9%)	0.221
	No	136 (41.6%)	12 (38.7%)
	NA	31 (9.5%)	6 (19.4%)
Stroke	Yes	6 (1.8%)	0	0.447
	No	321 (98.2%)	31 (100%)
DVT	Yes	1 (0.3%)	2 (6.5%)	<0.001
	No	326 (99.7%)	29 (93.5%)
PE	Yes	0	2 (6.5%)	<0.001
	No	327 (100%)	29 (93.5%)
COPD	Yes	0	0
	No	327 (100%)	31 (100%)
ASD or VSD	Yes	0	1 (3.2%)	0.001
	No	327 (100%)	30 (96.8%)
Beta-blocker	Yes	196 (59.9%)	20 (64.5%)	0.619
	No	131 (40.1%)	11 (35.5%)

Table 4 Effects of Smoking on Biochemical Factors, Associated Risk Factors and Beta-Blocker Intake in Patients with IHD

Variables		Current Smoker, n (%)	Ex-Smoker, n (%)	Non-Smoker, n (%)	P-value
WBC count	Low	0	2 (7.7%)	0	0.007
	Normal	188 (66.7%)	18 (69.2%)	35 (70%)
	High	94 (33.3%)	6 (23.1%)	15 (30%)
Platelets count	Low	12 (4.3%)	1 (3.8%)	0	0.670
	Normal	247 (87.6%)	22 (84.6%)	46 (92%)
	High	23 (8.1%)	3 (11.5%)	4 (8%)
Initial troponin	Low	0	0	0	0.266
	Normal	37 (13.1%)	6 (23.1%)	4 (8%)
	High	94 (33.3%)	7 (28.9%)	13 (26%)
	NA	151 (53.5%)	13 (50%)	33 (66%)
CK-MB	Low	0	0	1 (2%)	0.242
	Normal	59 (20.9%)	7 (26.9%)	11 (22%)
	High	110 (39%)	9 (34.6%)	15 (30%)
	NA	113 (40.1%)	10 (38.5%)	23 (46%)
Initial CK	Low	0	0	0	0.620
	Normal	77 (27.3%)	8 (30.8%)	16 (32%)
	High	92 (32.6%)	9 (34.6%)	11 (22%)
	NA	113 (40.1%)	9 (34.6%)	23 (46%)
HDL level	Low	207 (73.4%)	16 (61.5%)	36 (72%)	0.367
	Normal	60 (21.3%)	10 (38.5%)	10 (20%)
	High	3 (1.1%)	0	0
	NA	12 (4.2%)	0	4 (8%)
LDL level	Low	1 (0.4%)	0	0	0.737
	Normal	215 (76.2%)	18 (69.2%)	41 (82%)
	High	52 (18.4%)	5 (19.2%)	6 (12%)
	NA	14 (5%)	3 (11.5%)	3 (6%)
Triglycerides level	Low	0	0	2 (4%)	0.004
	Normal	105 (37.2%)	12 (46.2%)	24 (48%)
	High	165 (58.5%)	14 (53.8%)	22 (44%)
	NA	12 (4.3%)	0	2 (4%)
Cholesterol level	Low	7 (2.5%)	1 (3.8%)	0	0.383
	Normal	191 (67.7%)	17 (65.4%)	39 (78%)
	High	72 (25.5%)	8 (30.8%)	8 (16%)
	NA	12 (4.3%)	0	3 (6%)
Glucose level	Low	3 (1.1%)	0	1 (2%)	0.679
	Normal	111 (39.4%)	13 (50%)	15 (30%)
	High	144 (51.1%)	12 (46.2%)	30 (60%)
	NA	24 (8.5%)	1 (3.8%)	4 (8%)
Diabetes mellitus	Yes	73 (25.9%)	9 (36%)	19 (38%)	0.145
	No	209 (74.1%)	16 (64%)	31 (62%)
Hypertension	Yes	119 (42.2%)	13 (52%)	29 (58%)	0.091
	No	163 (57.8%)	12 (48%)	21 (42%)
Family history	Yes	77 (27.3%)	5 (19.2%)	12 (24%)	0.175
	No	205 (72.3%)	21 (80.8%)	38 (76%)
Obesity	Yes	135 (47.9%)	14 (53.8%)	24 (48%)	0.727
	No	118 (41.8%)	11 (42.3%)	19 (38%)
	NA	29 (10.3%)	1 (3.8%)	7 (14%)
Stroke	Yes	4 (1.4%)	1 (3.8%)	1 (2%)	0.641
	No	278 (98.6%)	25 (96.2%)	49 (98%)
DVT	Yes	2 (0.7%)	0	1 (2%)	0.582
	No	279 (99.3%)	26 (100%)	49 (98%)
PE	Yes	1 (0.4%)	0	1 (2%)	0.328
	No	281 (99.6%)	26 (100%)	49 (98%)
COPD	Yes	0	0	0
	No	282 (100%)	26 (100%)	50 (100%)
ASD or VSD	Yes	1 (0.4%)	0	0	0.874
	No	281 (99.6%)	26 (100%)	50 (100%)
Beta-blocker	Yes	163 (57.8%)	18 (69.2%)	35 (70%)	0.142
	No	119 (42%)	8 (30%)	15 (30%)